GUGGENHEIM CAPITAL LLC - THRESHOLD PHARMACEUTICAL INC ownership

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of THRESHOLD PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2017$9,000
-30.8%
22,7670.0%0.00%
Q1 2017$13,000
+30.0%
22,767
+0.6%
0.00%
Q4 2016$10,000
-33.3%
22,6310.0%0.00%
Q3 2016$15,0000.0%22,631
-1.2%
0.00%
Q2 2016$15,000
+25.0%
22,900
-5.8%
0.00%
Q1 2016$12,00024,3200.00%
Other shareholders
THRESHOLD PHARMACEUTICAL INC shareholders Q3 2017
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 393,000$1,556,0001.48%
FORTALEZA ASSET MANAGEMENT INC/ 98,125$389,0000.18%
Rhenman & Partners Asset Management AB 121,537$481,0000.14%
Baker Brothers Advisors 1,826,358$7,232,0000.09%
Rotella Capital Management, Inc. 21,600$86,0000.07%
SSI INVESTMENT MANAGEMENT LLC 117,640$466,0000.04%
FEDERATED HERMES, INC. 2,391,400$9,470,0000.03%
TFS CAPITAL LLC 96,659$383,0000.03%
SMITH ASSET MANAGEMENT GROUP LP 191,038$757,0000.03%
FRANKLIN STREET ADVISORS INC /NC 28,000$111,0000.02%
View complete list of THRESHOLD PHARMACEUTICAL INC shareholders